{"transactions":[{"id":1118898,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:20:39.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14492,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0000950170-25-083765","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083765/ownership.xml","form_type":"4"}},{"id":1118897,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:20:39.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-25-083765","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083765/ownership.xml","form_type":"4"}},{"id":1118896,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-09T20:20:39.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":9632,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":22504,"source":{"system":"sec-edgar","filing":"0000950170-25-083765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083765/ownership.xml","form_type":"4"}},{"id":1416894,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-09-04T11:40:42.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":false,"shares":12872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on September 2, 2023 and vested on September 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on September 2, 2023 and vested on September 2, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12872},"source":{"system":"sec-edgar","filing":"0000950170-24-103113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024103113/ownership.xml","form_type":"4"}},{"id":1416893,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-09-04T11:40:42.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":true,"shares":12872,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":12872,"source":{"system":"sec-edgar","filing":"0000950170-24-103113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024103113/ownership.xml","form_type":"4"}},{"id":1485685,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-10T11:53:23.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":9632,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-24-071081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024071081/ownership.xml","form_type":"4"}},{"id":1789999,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-09-05T20:05:07.000Z","date":"2023-09-02","kind":"grant","planned":false,"acquired":true,"shares":12872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on September 2, 2023 and vest on September 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on September 2, 2023 and vest on September 2, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":12872,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12872},"source":{"system":"sec-edgar","filing":"0001209191-23-048125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123048125/doc4.xml","form_type":"4"}},{"id":2625151,"issuer":{"id":7728,"kind":"organization","name":"Pluri Inc."},"owners":[{"id":78766,"kind":"person","name":"Shalev Varda","position":1,"cik":"0001873934","reported_name":"Shalev Varda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-26T20:24:45.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal instalments every 3 months thereafter."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001213900-21-038645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1158780/000121390021038645/ownership.xml","form_type":"4"}}]}